Trinity Biotech PLC (NASDAQ:TRIB)

18.36
Delayed Data
As of Mar 26
 -0.06 / -0.33%
Today’s Change
14.00
Today|||52-Week Range
26.00
+4.85%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Trinity Biotech PLC have a median target of 26.50, with a high estimate of 30.00 and a low estimate of 21.00. The median estimate represents a +44.34% increase from the last price of 18.36.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Trinity Biotech PLC. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.17
Sales
$25.9M
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -1.99%
 
 
 
 
 
 
Growthannually 12.51%
 
 
 
 
 
 

Sales

Growthquarterly -2.86%
 
 
 
 
 
 
Growthannually 7.83%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account